Brief: vTv Therapeutics Inc Says co's Dec. 6 Strategic Decision Includes Reduction In Workforce Affecting About 65% Of Employees
07/12/2021 11:09
Dec 7 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS INC SAYS CO'S DECEMBER 6 STRATEGIC
DECISION
INCLUDES REDUCTION IN WORKFORCE AFFECTING ABOUT 65% OF EMPLOYEES
- SEC FILING
* VTV THERAPEUTICS INC SAYS EXPECTS TO INCUR SEVERANCE
COSTS OF
ABOUT $1.5 MILLION
* VTV THERAPEUTICS INC SAYS EXPECTS STRATEGIC DECISION
ACTIONS TO
RESULT IN ANNUALIZED COST SAVINGS OF ABOUT $2.8 MILLION
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)